Conmed Corp (NASDAQ:CNMD)
During the Trading Day
| 34.04 |  +0.50 / +1.49% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 34.04 |  0.00 / 0.00% |
Volume: 1.2K |
Latest CNMD News | Press Releases
| Omnicell Pinned at Neutral - Analyst Blog 2:14pm / Zacks.com | Patterson Cos Posts In-Line Earnings - Analyst Blog May 23 / Zacks.com |
| Promising Data on Edwards' Sapien XT - Analyst Blog May 23 / Zacks.com | Has CONMED Made You Any Real Money? May 14 / MotleyFool.com |
Today’s Trading
| Previous close | 33.54 |
| Today’s open | 33.59 |
| Day’s range | 33.26 - 34.06 |
| Volume | 216,445 |
| Average volume (3 months) | 134,758 |
| Market cap | $930.1M |
| Dividend yield | 1.76% |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +4,600.00% |
| Earnings growth (this year) | +3.33% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +5.80% |
| P/E ratio | 23.8 |
| Price/Sales | 1.03 |
| Price/Book | 1.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CMNCantel Medical Corp | +0.23 | +0.68% |
| PCRXPacira Pharmaceutica... | -0.43 | -1.45% |
| SPNCSpectranetics Corp | -0.26 | -1.35% |
| MDXGMiMedx Group Inc | -0.19 | -2.66% |
Data as of 4:03pm ET, 05/24/2013
Financials
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $767.1M |
| Annual profit (last year) | $40.5M |
| Net profit margin | 5.28% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman Eugene R. Corasanti |
President, Chief Executive Officer & Director Joseph J. Corasanti |
Corporate headquarters Utica, New York |
Forecasts
